Richard A. Mortimer

Senior Advisor
Richard A. Mortimer

Education

Ph.D., economics, University of California, Berkeley; B.A., economics, Johns Hopkins University

Summary of Experience

Dr. Mortimer specializes in health economics, industrial organization, microeconomic theory, and econometrics. He has extensive experience with issues involving competition, intellectual property, marketing, pricing, and valuation with a focus on pharmaceuticals and the health care industry. His analyses have addressed issues of pricing, profitability, and payment flows at all levels of the distribution chain for pharmaceuticals and other health care products and services. He has evaluated and provided expert testimony on questions of causation, damages, class certification, and valuation in a variety of health care cases, including cases involving allegations of False Claims Act (FCA) and Anti-Kickback Statute (AKS) violations, Lanham Act matters, and antitrust matters. In addition to his work in litigation, Dr. Mortimer has assisted pharmaceutical and medical device manufacturers on pricing and contracting issues and authored several public policy studies related to legislation establishing a biosimilar approval pathway, biosimilar competition, pharmaceutical pricing, generic drug competition and the role of authorized generic entry, and paragraph IV abbreviated new drug application (ANDA) filings. His research has been published in leading peer-reviewed journals, including Health Affairs, Nature Reviews Drug Discovery, The Journal of Industrial Economics, and the Journal of Medical Economics.